Editas Medicine, Inc.·4

Nov 10, 4:28 PM ET

Michaels Lisa Anne 4

4 · Editas Medicine, Inc. · Filed Nov 10, 2020

Insider Transaction Report

Form 4
Period: 2020-11-09
Michaels Lisa Anne
EVP/Chief Medical Officer
Transactions
  • Award

    Common Stock

    2020-11-09+20,00020,000 total
  • Award

    Stock Option (right to buy)

    2020-11-09+120,000120,000 total
    Exercise: $30.41Exp: 2030-11-08Common Stock (120,000 underlying)
Footnotes (2)
  • [F1]The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years in equal yearly installments of one-fourth of the shares, with the first such installment to vest on November 9, 2021 continuing through November 9, 2024.
  • [F2]This option was granted on November 9, 2020 and is scheduled to vest over four years, with 25% of the shares to vest on November 9, 2021 and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through November 9, 2024.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -